1. Assessment of EGFR mutation status in Tunisian patients with pulmonary adenocarcinoma
- Author
-
S. Rammeh Rommani, A. Blel, M. Ksentinini, M.S. Boudaya, A. Arfaoui Toumi, Zidi Y, H. Zaibi, H. Aouina, R. Aloui, and N. Znaidi
- Subjects
0301 basic medicine ,Adult ,Male ,Lung Neoplasms ,Tunisia ,DNA Mutational Analysis ,Adenocarcinoma of Lung ,Real-Time Polymerase Chain Reaction ,General Biochemistry, Genetics and Molecular Biology ,law.invention ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Gene Frequency ,law ,Anaplastic lymphoma kinase ,Medicine ,Humans ,Anaplastic Lymphoma Kinase ,Genetic Predisposition to Disease ,Epidermal growth factor receptor ,Polymerase chain reaction ,Aged ,Aged, 80 and over ,Lung ,biology ,business.industry ,General Medicine ,Middle Aged ,medicine.disease ,Subtyping ,ErbB Receptors ,030104 developmental biology ,Real-time polymerase chain reaction ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Mutation ,Cancer research ,biology.protein ,Adenocarcinoma ,Female ,Antibody ,business - Abstract
Background Despite recent advances, non-small cell lung cancer carries a grim prognosis. For appropriate treatment selection, the updated guidelines recommend broad molecular profiling for all patients with pulmonary adenocarcinoma. Precise histological subtyping and targeted epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) testing are mandatory. Methods Herein, we assessed the EGFR mutation status of 26 formalin fixed-paraffin embedded (FFPE) samples of lung adenocarcinoma. Mutational analysis concerned exons 18–21 of EGFR by real-time polymerase chain reaction (Real time-PCR) using the Therascreen EGFR RGQ PCR mutation kit. ALK status was established on 22 among 26 patients using D5F3 antibody with a fully automated Ventana CDx technique. Results Activating EGFR mutations were found in 3 men among 26 patients (11.5%). Positive ALK expression was found in 2 cases among 22 patients (9.09%). Conclusion Frequency of EGFR mutations in pulmonary adenocarcinomas of our series is similar to that found in the European ones with some particularities. The mutations detected are uncommon. Whereas, we found a high frequency of positive ALK expression in our series compared to frequency reported in literature. Further studies with larger Tunisian series are required to obtain more conclusive results.
- Published
- 2017